These correlations of NR0B2 expression with patient overall survival status for renal cancers and lung cancers were consistent with the data obtained from a different bioinformatic platform except in breast cancer patients, as shown in Figure S2. The gene discussed is NR0B2; the disease is breast carcinoma.